Comparison of the efficacy, adverse effects, and cost of zoledronic acid and denosumab in the treatment of osteoporosis

Injectable osteoporosis drugs are increasing in popularity due to their efficacy and convenient administration. In this retrospective comparison of the two available treatments, denosumab (Prolia®) and zoledronic acid (ZA, Reclast®), we aimed to determine and compare the efficacy and tolerability of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Endocrine practice 2015-03, Vol.21 (3), p.275-279
Hauptverfasser:	Sheedy, Kellen C, Camara, Maria I, Camacho, Pauline M
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Bone Density - drug effects Bone Density Conservation Agents - therapeutic use Cohort Studies Denosumab - adverse effects Denosumab - therapeutic use Diphosphonates - adverse effects Diphosphonates - therapeutic use Female Humans Imidazoles - adverse effects Imidazoles - therapeutic use Male Osteoporosis - drug therapy Retrospective Studies Surveys and Questionnaires Zoledronic Acid
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!